UPDATED Apr 16, 2024
Discover Danish Pharmaceuticals & Biotech Growth Stocks that are on the OMX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ZEAL | kr.598.50 | -2.4% | 168.4% | kr.37.7b | kr.754.29 | PS108.7x | E44.6% | n/a | ||
ALK B | kr.126.20 | 1.9% | 52.8% | kr.28.2b | kr.125.00 | PE57.4x | E31.0% | 0% | ||
GMAB | kr.2,007.00 | -3.8% | -27.6% | kr.133.8b | kr.2,434.00 | PE30x | E21.5% | n/a | ||
NOVO B | kr.871.30 | 0.6% | 55.3% | kr.3.9t | kr.904.20 | PE46.5x | E14.8% | 1.1% | ||
CHEMM | kr.298.40 | -19.7% | -16.4% | kr.5.4b | kr.462.50 | PE36.1x | E12.8% | 2.0% | ||
HLUN B | kr.32.88 | -1.9% | -4.5% | kr.31.7b | kr.38.71 | PE14.2x | E9.9% | 2.1% | ||
BAVA | kr.149.15 | -1.1% | -22.2% | kr.11.9b | kr.276.80 | PE7.9x | E-16.8% | n/a | ||
STENO | kr.4.44 | -17.2% | -50.0% | kr.84.4m | n/a | PS20.2x | n/a | n/a | ||
GUBRA | kr.304.00 | 2.7% | 179.4% | kr.4.5b | n/a | PS24.2x | n/a | 0% | ||
BIOPOR | kr.1.27 | -0.5% | -17.1% | kr.480.6m | kr.5.00 | PS15.6x | n/a | n/a | ||
ORPHA | kr.1,050.00 | -3.3% | 30.9% | kr.37.1m | n/a | PB2.6x | n/a | n/a |